Country Highlights

Austria

Accord Austria has been set up in 2011 and has already accessed to the hospital market through its injectable oncology products. Throughout 2012 there will be launched already more than 10 molecules in the retail segment.
Read more

Belgium

Accord Belgium has been set up early 2012 and will focus mainly on the hospital sector.
Read more

Bulgaria

Accord is currently commercialising its products through an exclusive partnership with Pharmacons Inc.
Read more

Cyprus

Accord is currently commercialising its products through an exclusive partnership with Pharmasin.
Read more

Czech Rep.

Accord Czech Republic has been set up in October 2015 and will focus mainly on the hospital sector.
Read more

Denmark

The Danish commercial operations have been active since 2011. Through their oral and injectable oncology products it is foreseen to succeed in the retail and hospital markets.
Read more

Estonia

The Estonian commercial operations became active beginning 2012 and it accesses both, retail and hospital markets through its product offering.
Read more

Finland

Accord Finland has been set up in early 2011 and has successfully entered the hospital and retail markets. It is expected to reinforce hospital market presence by securing some regional tender awards mainly with our oncology range.
Read more

France

Accord France has been set up in 2008 and has successfully entered the hospital and retail markets by offering a robust product portfolio becoming now one of our most mature and consolidated markets in Europe.
Read more

Germany

The German commercial operations have become active in January 2012 and it is expected to rapidly penetrate the hospital channel through its injectable oncology product offering.
Read more

Hungary

Accord is currently commercialising its retail products through an exclusive partnership with Pharmacenter.
Read more

Iceland

Accord is currently commercializing its products through a partnership with Artasan and Portfarma.
Read more

Ireland

Accord Ireland has successfully entered the hospital market and is supplying the retail pharmacy market via wholesalers.
Read more

Italy

Accord Italy, in line with our CSR philosophy, has largely contributed to cancer patients by introducing a cancer patient oriented program named Kit Appunti di un Viaggio which has not only provided benefit to patients, but also has contributed to the hospital expense reduction.
Read more

Latvia

The Latvian commercial operations became active beginning 2013 and it accesses both, retail and hospital markets through its product offering.
Read more

Lithuania

The Lithuanian commercial operations became active beginning 2013 and it accesses both, retail and hospital markets through its product offering.
Read more

Malta

Accord is currently commercialising its products through an exclusive partnership with Rodel Ltd.
Read more

Netherlands

Accord Netherlands has been active since 2008. After successful entry of the retail market Accord expanded it’s commercial activities to the hospital market in 2011.
Read more

Norway

The Norwegian commercial operations have been active since 2012 and it has successfully entered the hospital markets.
Read more

Poland

The incorporation of Accord Poland as an affiliate has strategic importance for the Hospital products business. Poland has a population of approximately 38 million people and is the largest CEE market available inside the EU, with a target market of approximately 600 hospitals and 150 oncology units. Poland is predominantly tender driven in hospital but there is a significant “open care” market which could be exploited in the future. Accord expects to succeed on this market and to generate sales of approximately €1.5m during the first year. The robust experience of the Polish team appointed to lead this exciting challenge will be fundamental for the accomplishment of the objectives of this new Accord affiliate.
Read more

Portugal

Accord was established in Portugal in 2014, with a commitment to bring the Hospitals and their patients, generic exclusive hospital drugs in the areas of oncology and immunosuppression
Read more

Romania

Accord Romania has been set up in October 2015 and will focus mainly on the hospital sector.
Read more

Slovakia

Accord is currently commercialising its products through an exclusive partnership with Evopharm.
Read more

Slovenia

Accord Slovenia has been set up in October 2015 and will focus mainly on the hospital sector.
Read more

Spain

Accord Spain has successfully been set up in 2009 and has actively started commercializing its products from September 2010. It has successfully entered the hospital market with a robust oncology portfolio and also has strengthen it by signing an acquisition deal with Stada to acquire five more hospital products from their product portfolio. 
Read more

Sweden

Accord Sweden has been active since 2010 and has successfully entered the hospital and retail market through its quality products offering. It is foreseen consolidating its presence in the hospital market by securing regional tender awards for the coming years.
Read more

UK

Accord UK has been set up in 2008 as a regional office and European Headquarters. From our laboratories in the European Headquarters product is retested and batch- released as well.
Read more